🔗 Share this article

Given that the US undertakes historic revisions to its vaccination recommendations, a particular individual has surfaced in a surprising turn: Høeg, a US-based physician and epidemiologist who initially gained attention by expressing skepticism about Covid vaccines throughout the global health crisis and has zeroed in on possible fatalities after Covid vaccination in her brief time at the US Food and Drug Administration (FDA).

Scheduled Overhauls to Pediatric Immunization Schedule

Health officials were set to unveil major changes to the pediatric vaccine schedule recently, aligning the US with Denmark’s national calendar, according to reports – a major change that would place the US out of alignment with much of the global community with little proof for benefit. The announcement has been delayed until the coming year.

Rather than the top vaccines chief, Tracy Beth Høeg is listed to speak at the event. She was recently named interim head of the FDA’s drug evaluation center, the fifth person to run the center this year.

A Shift at the Regulatory Body

Høeg's temporary position might represent a strengthened alliance between the pharmaceutical and vaccine centers as Høeg and Dr. Prasad solidify control at the regulatory agency – and it points to a increased emphasis upon dismantling previously authorized vaccines at the FDA.

The new acting director has often pushed for ending certain pediatric vaccine recommendations in the US so as to align more like Denmark's approach, a country with comprehensive healthcare and a number of inhabitants about the size of the state of Wisconsin.

So far public appearances, she has persisted in emphasizing on vaccination policy – typically the domain of Dr. Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than medication approval.

Concerns Over Background

Høeg has no obvious track record in medication creation, oversight or leadership, which has been standard for previous leaders of the CBER. She has served at the FDA as a top consultant to the FDA chief and the vaccine center since spring.

“She doesn’t seem to have the necessary background” for running the CDER, remarked a neurologist and psychiatrist. “She has not conducted a scientific study. She has no expertise in managing a sizeable institution. She is not an expert in pharmaceutical oversight.”

Past directors of the center would “understand laws and regulations and the research of medication creation”, noted Janet Woodcock. “Clearly, she lacks the kind of background that former directors who ran CBER have had.”

CDER has an vast portfolio at the FDA, she emphasized.

“Many people just zeroes in on the innovative therapies, but the off-patent medication office approves thousands of generic medications. There is also a biologic copycat branch, OTC medication office and other areas, and all of those need to be supervised,” Dr. Woodcock explained. “The responsibility you neglect, that is precisely what that I always told people is going to come back to haunt you.”

Furthermore, a significant administrative component to the job, which supervises over 5,000 employees. “It’s a huge management job, if you execute it properly,” she concluded.

Response and Disputed Initiatives

Regarding questions about Høeg’s credentials and whether this assignment represents greater collaboration among FDA leaders on immunizations, a spokesperson responded that the “concerns are based on flawed assumptions”.

“Her experience aligns with the responsibilities of her job,” the representative explained, citing the months Dr. Høeg spent advising the FDA commissioner on “drug safety and regulatory science, including computational safety modeling and immunization monitoring”.

As the temporary head, Dr. Høeg inherits the agency head's controversial expedited review system, a contentious one-day drug-approval program that apparently worried her preceding directors. “How are these drugs being chosen for this voucher program? Who makes the decisions?” Dr. Howard said. “There’s a lot of secrecy happening at the agency right now.”

In general, he stated, “the FDA appears to be shifting towards less stringent regulations of all drugs, aside from vaccines.”

Established History on Vaccines

With vaccines, Høeg has a more documented, if problematic, track record, Howard observe. She authored a study using unconfirmed crowd-sourced reports to estimate the rate of heart inflammation following Covid vaccination. She advised the state of Florida chief medical officer Dr. Joseph Ladapo, who reportedly have altered data to imply COVID-19 vaccines are pose a greater threat than they are.

Included in her “wish list” for the new federal leadership featured altering rules for new vaccines and discontinuing “unnecessary” vaccines, she stated after the election on a online show. At the agency, Høeg has according to sources floated the idea of barring adolescent males from getting Covid vaccines.

“She is an complete ideologue who commences with her beliefs and reverse-engineers to accommodate the evidence in a very deceptive, dishonest way,” Dr. Howard argued.

Taking Control and a “Revenge Tour”

Dr. Høeg joined other dissenters, {like|